Extracorporeal shockwave therapy (ESWT) is a non-surgical, non-injection treatment that uses focused acoustic pressure waves to stimulate the body’s own healing response in chronically injured tendons and fascia. The technology was originally developed to break up kidney stones (lithotripsy) and later adapted for musculoskeletal medicine, where three decades of clinical research have established it as an effective option for conditions that fail to respond to rest, orthotics, and physical therapy alone.

At Michigan Avenue Podiatry, shockwave therapy is performed by Dr. Mohammad Usman, DPM, a board-certified podiatric physician and foot & ankle surgeon practicing at our Chicago office on Michigan Avenue. Dr. Usman uses ESWT as part of a comprehensive conservative care pathway — reserving it for patients who have not achieved adequate relief from stretching, anti-inflammatory treatment, and custom orthotics. The procedure is performed in-office in 15–20 minutes, requires no anesthesia, and allows patients to walk out the same day.

ESWT is available as a cash-pay procedure at Michigan Avenue Podiatry. Contact us at (312) 701-0770 to discuss pricing and whether shockwave therapy is right for your condition.

How Shockwave Therapy Works at the Cellular Level

During an ESWT session, a handheld applicator is placed against the skin over the target area — typically the heel, arch, or Achilles tendon. High-energy sound waves are delivered in focused pulses into the affected tissue. This acoustic energy creates controlled microtrauma that triggers a cascade of well-characterized biological responses:

• Neovascularization — formation of new blood vessels that restore nutrient and oxygen supply to the degenerated tissue
• Growth factor release — upregulation of transforming growth factor-beta 1 (TGF-β1), vascular endothelial growth factor (VEGF), and insulin-like growth factor 1 (IGF-1), which stimulate fibroblast activity and tissue repair
• Neocollagenesis — synthesis of new, organized type I collagen fibers that replace the disorganized, degraded matrix characteristic of chronic tendinopathy
• Neurogenic inhibition — substance P depletion in local sensory nerve fibers, which reduces chronic pain signaling beyond what can be explained by tissue repair alone
• Tenocyte proliferation — direct stimulation of tendon cell division and matrix synthesis, accelerating the remodeling phase of tissue healing

The result is genuine tissue repair rather than temporary pain suppression. Unlike cortisone injections, which reduce inflammation acutely but can weaken tendon tissue with repeated use (increasing rupture risk), ESWT addresses the underlying degenerative changes that characterize conditions like chronic plantar fasciitis and Achilles tendinopathy. A 2024 meta-analysis of 45 controlled studies found significant pain reduction with ESWT across multiple tendinopathy conditions (pmc.ncbi.nlm.nih.gov/PMC11041007/).

Focused vs. Radial Shockwave: What’s the Difference?

Two forms of extracorporeal shockwave therapy are used clinically: focused ESWT and radial pressure wave therapy (RSWT). Focused shockwave delivers high-energy acoustic waves converged at a precise tissue depth — typically 2–4 cm — making it optimal for deeper structures like the plantar fascia insertion or Achilles tendon. Radial pressure wave therapy delivers lower-energy waves that disperse from the skin surface outward, covering a broader superficial area. Both have supporting evidence, though focused ESWT generally produces higher peak energy levels at the target tissue.

The appropriate wave type and energy parameters are selected based on the specific condition being treated, the tissue depth of the pathology, and patient tolerance. Dr. Mohammad Usman determines the optimal protocol for each patient after a complete clinical examination and diagnostic imaging review.

Conditions Treated with Shockwave Therapy at Michigan Avenue Podiatry

Dr. Mohammad Usman uses shockwave therapy for several chronic foot and ankle conditions at our Chicago office. Each condition has its own evidence base, optimal energy parameters, and treatment protocol — follow the links below for condition-specific information including peer-reviewed research, clinical outcomes, and detailed FAQ sections:

• Shockwave therapy for plantar fasciitis — the most studied ESWT application in podiatric medicine; meta-analysis data supports 60–80% success rates vs. placebo at 12-month follow-up
• Shockwave therapy for Achilles tendinitis — effective for both insertional and non-insertional Achilles tendinopathy; evidence from randomized controlled trials across multiple research groups
• Shockwave therapy for heel pain and heel spurs — addresses calcaneal spurs and plantar fascial inflammation at the insertion; superior long-term outcomes compared to cortisone injection
• Shockwave therapy for metatarsalgia (ball-of-foot pain) — acoustic waves stimulate healing in the plantar plate and surrounding soft tissue structures of the forefoot

What to Expect at Your ESWT Appointment with Dr. Usman

Your first appointment begins with a comprehensive evaluation by Dr. Mohammad Usman, DPM. This includes a detailed history of your symptoms, a biomechanical examination, and — when clinically indicated — diagnostic ultrasound imaging to characterize the degree of tendon or fascial degeneration and confirm appropriate candidacy for shockwave therapy. Weight-bearing X-rays are obtained when heel spur assessment or bony pathology is part of the clinical picture.

Before treatment begins, ultrasound gel is applied to the skin over the treatment area. This gel serves as a coupling medium that allows acoustic waves to pass efficiently from the applicator into the underlying tissue with minimal energy loss. The applicator is then moved slowly over the target zone while delivering pulsed shockwaves at calibrated energy levels and frequencies.

Most patients experience mild to moderate discomfort during treatment, often described as a tapping or vibrating sensation with brief sharp intensity at the most affected area. This discomfort is expected and clinically meaningful — it indicates that the waves are reaching the target tissue. Patients typically rate ESWT discomfort at 3–5 out of 10 on a standard pain scale.

Sessions last 15–20 minutes. A standard ESWT course consists of 3–5 sessions spaced one week apart. No anesthesia or sedation is required. Patients can walk out of the office immediately after treatment, and there are no wound care requirements or activity restrictions beyond avoiding high-impact exercise in the 24–48 hours after each session.

Some patients notice mild soreness in the treated area for one to two days after each session — this is a normal part of the healing response and should not be confused with worsening of the original condition. Improvement typically begins in weeks 2–3, with full therapeutic effect continuing to develop over 6–12 weeks as tendon remodeling progresses.

The Clinical Evidence for ESWT

Shockwave therapy is among the best-studied conservative interventions for chronic tendinopathy. The evidence base has grown substantially over the past two decades, with multiple high-quality randomized controlled trials (RCTs), systematic reviews, and meta-analyses supporting its efficacy. Key research highlights:

• A 2024 meta-analysis of 45 controlled studies (PMC11041007) confirmed significant pain reduction with ESWT across tendinopathy conditions, with plantar fasciitis and Achilles tendinopathy among the strongest responders
• A 2017 RCT in the Journal of Orthopaedic Surgery and Research found ESWT significantly superior to placebo for chronic plantar fasciitis at all follow-up time points (PubMed 27977431)
• A 2023 systematic review confirmed ESWT efficacy for Achilles tendinopathy, with consistent outcomes across multiple study designs (PubMed 37662911)
• A 2022 comparative study found ESWT superior to ultrasound therapy for plantar fasciitis at all time points (PubMed 35145778)
• FDA clearance for ESWT in the treatment of plantar fasciitis has been in place since 2000; the technology has a well-established safety profile with over 20 years of clinical use

Is Shockwave Therapy Right for You?

ESWT is typically recommended when conservative measures — including rest, anti-inflammatory medications, custom orthotics, and physical therapy — have not provided adequate relief over a period of 3 months or more. Good candidates for shockwave therapy include patients with:

• Chronic plantar fasciitis (heel pain present for 3+ months despite conservative care)
• Achilles tendinopathy — insertional or non-insertional — that has not responded to eccentric strengthening
• Calcaneal heel spurs causing ongoing pain and soft tissue inflammation
• Metatarsalgia or plantar plate inflammation not responding to orthotics and activity modification
• Patients who cannot or do not wish to pursue surgical intervention
• Patients who have had prior cortisone injections with incomplete or temporary relief

ESWT is not indicated for patients with active infection in the treatment area, blood clotting disorders, open wounds over the target site, pregnancy, or certain systemic conditions. Dr. Usman will review your complete history, examination findings, and imaging before recommending the procedure.

Cash-Pay Pricing and What to Expect

ESWT at Michigan Avenue Podiatry is offered as a cash-pay procedure. This means it is not billed through insurance — you pay directly at the time of service. Cash-pay pricing covers the complete treatment course (typically 3–5 sessions) and is discussed in full during your initial consultation with Dr. Usman before any treatment is scheduled. There are no hidden facility fees or anesthesia costs.

Many patients find that ESWT represents a cost-effective alternative when weighed against the total cost of ongoing conservative treatment (repeat injections, continued physical therapy) or the expense and recovery time of surgical intervention. Call (312) 701-0770 to discuss current pricing during your consultation.

Frequently Asked Questions

How many shockwave therapy sessions are needed?
A standard course is 3–5 sessions, spaced one week apart. Most patients see meaningful improvement by weeks 2–3. Full tendon remodeling and peak benefit continue to develop over 6–12 weeks after the final session.

Is ESWT painful?
Mild to moderate discomfort during treatment is expected and normal — it indicates the acoustic waves are reaching the target tissue. Most patients rate the sensation at 3–5 out of 10. No anesthesia is required. Post-treatment soreness for 24–48 hours is common and is part of the healing process.

Does shockwave therapy require surgery or anesthesia?
No. ESWT is a completely non-surgical, non-injection outpatient procedure. The applicator is placed against the skin surface. No incisions, needles, or sedation are involved. Patients walk out of the office and resume normal activity the same day.

How much does shockwave therapy cost at Michigan Avenue Podiatry?
ESWT is a cash-pay procedure at our practice. Pricing is discussed during your consultation with Dr. Usman. Call (312) 701-0770 to learn more. The cost covers your complete treatment course — typically 3–5 sessions.

Who performs ESWT at Michigan Avenue Podiatry?
ESWT is performed by Dr. Mohammad Usman, DPM, a board-certified podiatric physician and foot & ankle surgeon. Dr. Usman evaluates each patient individually, reviews imaging, and designs a personalized treatment plan before any procedure is performed.

Is shockwave therapy covered by insurance?
Insurance coverage for ESWT varies by plan and carrier. At Michigan Avenue Podiatry, ESWT is offered on a cash-pay basis. We recommend calling your insurance carrier directly to ask about your specific plan’s coverage, but please be aware that many plans classify ESWT as investigational for certain indications. Our team will provide all the documentation you need to submit for reimbursement on your own if you wish.